131 related articles for article (PubMed ID: 36441045)
1. TP53 positivity combined with high fibrinogen expression defines a subtype of oral squamous cell carcinoma with an unfavorable prognosis.
Inoue A; Matsumoto T; Ito Y; Saegusa M; Takahashi H
Hum Pathol; 2022 Dec; 130():25-35. PubMed ID: 36441045
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of preoperative D-dimer, fibrinogen and platelet levels in patients with oral squamous cell carcinoma.
Liang YJ; Mei XY; Zeng B; Zhang SE; Yang L; Lao XM; Liao GQ
BMC Cancer; 2021 Feb; 21(1):122. PubMed ID: 33546637
[TBL] [Abstract][Full Text] [Related]
3. Assessing immuno-expression of p53 protein and TP 53 gene amplification in histologically negative surgical margins of oral squamous cell carcinoma patients and normal oral mucosa.
Kamat MS; Puranik RS; Das Rai AB; Patil BR; Patil S
Clin Oral Investig; 2022 Oct; 26(10):6235-6243. PubMed ID: 35674840
[TBL] [Abstract][Full Text] [Related]
4. Tumor-related markers in histologically normal margins correlate with locally recurrent oral squamous cell carcinoma: a retrospective study.
Wang X; Chen S; Chen X; Zhang C; Liang X
J Oral Pathol Med; 2016 Feb; 45(2):83-8. PubMed ID: 26260282
[TBL] [Abstract][Full Text] [Related]
5. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
Tang Y; Xiao Y; Liao R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG
Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449
[TBL] [Abstract][Full Text] [Related]
7. NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.
Arora R; Haynes L; Kumar M; McNeil R; Ashkani J; Nakoneshny SC; Matthews TW; Chandarana S; Hart RD; Jones SJM; Dort JC; Itani D; Chanda A; Bose P
Cancer Gene Ther; 2023 May; 30(5):752-765. PubMed ID: 36635327
[TBL] [Abstract][Full Text] [Related]
8. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of CD168 is related to poor prognosis in oral squamous cell carcinoma.
Zhu SW; Wang S; Wu ZZ; Yang QC; Chen DR; Wan SC; Sun ZJ
Oral Dis; 2022 Mar; 28(2):364-372. PubMed ID: 33386685
[TBL] [Abstract][Full Text] [Related]
10. Extracellular vesicles miR-210 as a potential biomarker for diagnosis and survival prediction of oral squamous cell carcinoma patients.
Bigagli E; Locatello LG; Di Stadio A; Maggiore G; Valdarnini F; Bambi F; Gallo O; Luceri C
J Oral Pathol Med; 2022 Apr; 51(4):350-357. PubMed ID: 34800057
[TBL] [Abstract][Full Text] [Related]
11. Functionally impactful TP53 mutations are associated with increased risk of extranodal extension in clinically advanced oral squamous cell carcinoma.
Gleber-Netto FO; Neskey D; Costa AFM; Kataria P; Rao X; Wang J; Kowalski LP; Pickering CR; Dias-Neto E; Myers JN
Cancer; 2020 Oct; 126(20):4498-4510. PubMed ID: 32797678
[TBL] [Abstract][Full Text] [Related]
12. Corneodesmosin as a potential target of oral squamous cell carcinoma.
Di YB; Bao Y; Guo J; Liu W; Zhang SX; Zhang GH; Li TK
Medicine (Baltimore); 2022 Sep; 101(39):e28397. PubMed ID: 36181011
[TBL] [Abstract][Full Text] [Related]
13. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
14. The expression of p53, p16 proteins and prevalence of apoptosis in oral squamous cell carcinoma. Correlation with mode of invasion grading system.
Tokman B; Gultekin SE; Sezer C; Alpar R
Saudi Med J; 2004 Dec; 25(12):1922-30. PubMed ID: 15711668
[TBL] [Abstract][Full Text] [Related]
15. A correlation of immunohistochemical expression of
Pandya JA; Natarajan S
J Cancer Res Ther; 2019; 15(3):564-570. PubMed ID: 31169221
[TBL] [Abstract][Full Text] [Related]
16. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
17. Associations between RORγt and T-bet Expressions, clinicopathological indices and survival rate in oral Squamous cell carcinoma patients.
Ghelichli M; Mohtasham N; Mohajertehran F; Farshbaf A; Anvari K; Taghipour A; Pakfetrat A; Ansari AH
Cytokine; 2023 Mar; 163():156116. PubMed ID: 36621309
[TBL] [Abstract][Full Text] [Related]
18. A correlation of immunohistochemical expression of
Pandya JA; Boaz K; Natarajan S; Manaktala N; Nandita KP; Lewis AJ
J Cancer Res Ther; 2018; 14(3):666-670. PubMed ID: 29893337
[TBL] [Abstract][Full Text] [Related]
19. Detection of human papillomavirus infection in oral squamous cell carcinoma: a cohort study of Japanese patients.
Kouketsu A; Sato I; Abe S; Oikawa M; Shimizu Y; Takahashi T; Kumamoto H
J Oral Pathol Med; 2016 Sep; 45(8):565-72. PubMed ID: 26711722
[TBL] [Abstract][Full Text] [Related]
20. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
[Next] [New Search]